Search

Search Constraints

You searched for: Author/Creator Furst, Sabine

Search Results

1. A matched‐pair analysis reveals marginally reduced CD34+ cell mobilization on second occasion in 27 related donors who underwent peripheral blood stem cell collection twice at the same institution. Issue 11 (18th October 2019)

2. Evaluation of a disease risk index for adult patients undergoing umbilical cord blood transplantation for haematological malignancies. (19th October 2017)

3. Fatal acute respiratory distress syndrome with diffuse alveolar damage: donor lymphocyte infusion imputability?. Issue 6 (1st September 2016)

4. Impact of minimal residual disease on outcomes after umbilical cord blood transplantation for adults with Philadelphia‐positive acute lymphoblastic leukaemia: an analysis on behalf of Eurocord, Cord Blood Committee and the Acute Leukaemia working party of the European group for Blood and Marrow Transplantation. (25th June 2014)

5. Long‐term outcome after allogeneic stem‐cell transplantation with reduced‐intensity conditioning in patients with multiple myeloma. Issue 5 (5th March 2013)

6. National Institutes of Health classification for chronic graft-versus-host disease predicts outcome of allo-hematopoietic stem cell transplant after fludarabine–busulfan–antithymocyte globulin conditioning regimen. Issue 5 (May 2014)

7. Outcomes after allogeneic hematopoietic stem cell transplantation for adults with primary mediastinal B cell lymphoma: a SFGM-TC and LYSA study. (2nd November 2022)

8. Reduced‐toxicity conditioning with fludarabine, once‐daily intravenous busulfan, and antithymocyte globulins prior to allogeneic stem cell transplantation: Results of a multicenter prospective phase 2 trial. Issue 4 (3rd October 2014)

9. Reduced‐toxicity conditioning with fludarabine, once‐daily intravenous busulfan, and antithymocyte globulins prior to allogeneic stem cell transplantation: Results of a multicenter prospective phase 2 trial. Issue 4 (3rd October 2014)

10. Tandem autologous-haploidentical transplantation is a feasible and effective program for refractory Hodgkin lymphoma. (March 2018)